← Leaderboards
Jason Ciril Kovacic
Icahn School Of Medicine At Mount Sinai
$5,346,791
Attributed
$8,351,257
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2012–23$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,351,257 · 5
By mechanism
R01$6,598,085 · 3
T32$1,105,847 · 1
K08$647,325 · 1
Top collaborators
- Daniella Kadian-Dodov4 shared
- Kenneth Michael Fish2 shared
- Bruce D Gelb2 shared
- Kiyotake Ishikawa1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Daniella Kadian-Dodov$1,398,979
- Kenneth Michael Fish$1,681,378
- Chenleng Cai$6,096,284
- Kiyotake Ishikawa$6,383,028
- Fatima A Sehba$1,686,313
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularIn VitroEndothelial CellsGenesCardiovascular SystemIn VivoAdultCessation Of LifePhenotypeBlood VesselsSmooth Muscle MyocytesEndotheliumCellsKnock-DownVectorInsightPre-ClinicalMediatingPlayArteriesEpidemicGeneticGenetic StudyApolipoprotein E
Grant awards (18)
Understanding the Molecular Mechanisms of Fibromuscular Dysplasia$676,197
R01 · FY2023 · HL
Understanding the Molecular Mechanisms of Fibromuscular Dysplasia$719,179
R01 · FY2022 · HL
Understanding the Molecular Mechanisms of Fibromuscular Dysplasia$719,179
R01 · FY2021 · HL
Therapeutic Mechanisms of Cardiac Progenitors in Ischemic Cardiomyopathy$840,689
R01 · FY2020 · HL
Understanding the Molecular Mechanisms of Fibromuscular Dysplasia$683,402
R01 · FY2020 · HL
Toward Therapeutic Manipulation of Endothelial to Mesenchymal Transition$423,750
R01 · FY2020 · HL
Therapeutic Mechanisms of Cardiac Progenitors in Ischemic Cardiomyopathy$840,689
R01 · FY2019 · HL
Training Program in Molecular and Cellular Cardiology$571,260
T32 · FY2019 · HL
Toward Therapeutic Manipulation of Endothelial to Mesenchymal Transition$423,750
R01 · FY2019 · HL · contact PI
Training Program in Molecular and Cellular Cardiology$534,587
T32 · FY2018 · HL
Toward Therapeutic Manipulation of Endothelial to Mesenchymal Transition$423,750
R01 · FY2018 · HL · contact PI
Toward Therapeutic Manipulation of Endothelial to Mesenchymal Transition$423,750
R01 · FY2017 · HL · contact PI
Toward Therapeutic Manipulation of Endothelial to Mesenchymal Transition$423,750
R01 · FY2016 · HL · contact PI
Cellular and molecular mechanisms of endothelial repair and atherosclerosis$129,465
K08 · FY2016 · HL · contact PI
Cellular and molecular mechanisms of endothelial repair and atherosclerosis$129,465
K08 · FY2015 · HL · contact PI
Cellular and molecular mechanisms of endothelial repair and atherosclerosis$129,465
K08 · FY2014 · HL · contact PI
Cellular and molecular mechanisms of endothelial repair and atherosclerosis$129,465
K08 · FY2013 · HL · contact PI
Cellular and molecular mechanisms of endothelial repair and atherosclerosis$129,465
K08 · FY2012 · HL · contact PI